España
Acceder
Cotización de Atea Pharmaceuticals, Inc. (AVIR) hoy en tiempo real
Análisis técnico y gráfico histórico de Atea Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Atea Pharmaceuticals, Inc.
Ficha de Atea Pharmaceuticals, Inc. (AVIR)
| Ticker | AVIR |
|---|---|
| ISIN | US04683R1068 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Atea Pharmaceuticals, Inc.
Resumen financiero e información corporativa de Atea Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Atea Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Atea Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Atea Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Atea Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Atea Pharmaceuticals, Inc.
Invertir en Atea Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Atea Pharmaceuticals, Inc.?
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of de...
¿En qué sector opera Atea Pharmaceuticals, Inc.?
Atea Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.